Stock Research for CMRX

CMRX
Current Price

$4.8800


Latest Update: 2018-02-23 16:00:00

High
$ 4.8900
Low
$ 4.8800
Close
$ 4.8900
Volume
14153
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

CMRX Stock Chart & Research Data

The CMRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CMRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CMRX Due diligence Resources & Stock Charts

The CMRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CMRX Detailed Price Forecast - CNN Money CNN View CMRX Detailed Summary - Google Finance
Yahoo View CMRX Detailed Summary - Yahoo! Finance Zacks View CMRX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CMRX Trends & Analysis - Trade-Ideas Barrons View CMRX Major Holders - Barrons
NASDAQ View CMRX Call Transcripts - NASDAQ Seeking View CMRX Breaking News & Analysis - Seeking Alpha
Spotlight View CMRX Annual Report - CompanySpotlight.com OTC Report View CMRX OTC Short Report - OTCShortReport.com
TradeKing View CMRX Fundamentals - TradeKing Charts View CMRX SEC Filings - Bar Chart
WSJ View Historical Prices for CMRX - The WSJ Morningstar View Performance/Total Return for CMRX - Morningstar
MarketWatch View the Analyst Estimates for CMRX - MarketWatch CNBC View the Earnings History for CMRX - CNBC
StockMarketWatch View the CMRX Earnings - StockMarketWatch MacroAxis View CMRX Buy or Sell Recommendations - MacroAxis
Bullish View the CMRX Bullish Patterns - American Bulls Short Pains View CMRX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CMRX Stock Mentions - StockTwits PennyStocks View CMRX Stock Mentions - PennyStockTweets
Twitter View CMRX Stock Mentions - Twitter Invest Hub View CMRX Investment Forum News - Investor Hub
Yahoo View CMRX Stock Mentions - Yahoo! Message Board Seeking Alpha View CMRX Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for CMRX - SECform4.com Insider Cow View Insider Transactions for CMRX - Insider Cow
CNBC View CMRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CMRX - OTC Markets
Yahoo View Insider Transactions for CMRX - Yahoo! Finance NASDAQ View Institutional Holdings for CMRX - NASDAQ


Stock Charts

FinViz View CMRX Stock Insight & Charts - FinViz.com StockCharts View CMRX Investment Charts - StockCharts.com
BarChart View CMRX Stock Overview & Charts - BarChart Trading View View CMRX User Generated Charts - Trading View


Latest Financial News for CMRX

Chimerix to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018
Posted on Thursday February 22, 2018

DURHAM, N.C., Feb. 22, 2018-- Chimerix, Inc., a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that it will host a live ...


Could These 2 Biotech Stocks Really Double Your Money?
Posted on Thursday February 15, 2018

Analyst price targets for these two biotechs suggest they could double your money. Here's what you need to know.


Wired News – Chimerix Announced Initiation of AdAPT Study for Oral Brincidofovir and Advancement of IV Brincidofovir to Phase-2 Studies
Posted on Monday January 08, 2018

LONDON, UK / ACCESSWIRE / January 08, 2018 / Active-Investors.com has just released a free research report on Chimerix, Inc. (NASDAQ: CMRX ). If you want access to this report all you need to do is sign ...


Recent Analysis Shows Chimerix, Highwoods Properties, HubSpot, Biglari, IDEXX Laboratories, and Argan Market Influences — Renewed Outlook, Key Drivers of Growth
Posted on Friday January 05, 2018

NEW YORK, Jan. 05, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Chimerix, ...


Opaleye Management Inc. Sells 803000 Shares of Chimerix Inc (CMRX)
StockNewsTimes - Nov 10, 2017
Chimerix logo Opaleye Management Inc. decreased its holdings in shares of Chimerix Inc (NASDAQ:CMRX) by 57.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC.
Chimerix Inc (CMRX) Position Reduced by Opaleye Management Inc. - Week Herald
IMAX (IMAX) Coveraged By JP Morgan with $28.0 Target; Chimerix (CMRX) Shorts ... - UtahHerald.com

Chimerix to Announce Fourth Quarter and Full Year 2017 Financial Results on ...
GlobeNewswire (press release) - Feb 22, 2018
DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that it will host a live conference call and ...

Chimerix - Years Behind The Competition
Seeking Alpha - Feb 9, 2018
Chimerix (CMRX) is an antiviral company that has a Phase III clinical trial studying the effects of its primary drug Brincidofovir for the treatment of adenovirus infections in immune compromised patients as its lead candidate indication.

EPS for Chimerix, Inc. (CMRX) Expected At $-0.48
Frisco Fastball - 16 hours ago
Gsa Prns Llp holds 0.02% in Chimerix, Inc. (NASDAQ:CMRX) or 50,067 shares. Rhenman & Prtnrs Asset Management accumulated 0.27% or 400,000 shares.
Chimerix, Inc. (CMRX) Analysts See $-0.48 EPS - KL Daily

Enter a stock symbol to view the stock details.